A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
Erica Brivio, Franco Locatelli, Marta Lopez-Yurda, Andrea Malone, Cristina Díaz-de-Heredia, Bella Bielorai, Claudia Rossig, Vincent H J van der Velden, Anneke C J Ammerlaan, Adriana Thano, Inge M van der Sluis, Monique L den Boer, Ying Chen, Barbara Sleight, Benoit Brethon, Karsten Nysom, Lucie Sramkova, Ingrid Øra, Luciana Vinti, Christiane Chen-SantelChristian Michel Zwaan
Research output: Contribution to journal › Article › peer-review
64Citations
(Scopus)
Fingerprint
Dive into the research topics of 'A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)'. Together they form a unique fingerprint.